A quinoxaline-based compound ameliorates bone loss in ovariectomized mice.
Animals
Bone Density
/ drug effects
Bone Resorption
/ drug therapy
Disease Models, Animal
Female
Glucagon-Like Peptide 1
/ metabolism
Glucagon-Like Peptide-1 Receptor
/ agonists
Menopause
/ physiology
Mice
Mice, Inbred C57BL
Osteoclasts
/ drug effects
Osteogenesis
/ drug effects
Osteoporosis
/ drug therapy
Quinoxalines
/ pharmacology
6,7-dichloro-2-methylsulfonyl-3-Ntert-butylaminoquinoxaline
Osteoporosis
bone metabolism
glucagon-like peptide 1 receptor
small molecule agonist
Journal
Experimental biology and medicine (Maywood, N.J.)
ISSN: 1535-3699
Titre abrégé: Exp Biol Med (Maywood)
Pays: England
ID NLM: 100973463
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
pubmed:
27
7
2021
medline:
28
12
2021
entrez:
26
7
2021
Statut:
ppublish
Résumé
DMB (6,7-dichloro-2-methylsulfonyl-3-Ntert-butylaminoquinoxaline) is a quinoxaline-based compound that has been investigated as a glucagon-like peptide-1 receptor (GLP-1R) agonist. To clarify anti-osteoporosis effect of DMB, an osteoporotic mice model was established by ovariectomy (OVX) operation. The OVX mice were given intraperitoneally DMB, exendin-4 (EX-4), or 17β-estradiol (E
Identifiants
pubmed: 34308655
doi: 10.1177/15353702211032133
pmc: PMC8649934
doi:
Substances chimiques
Glucagon-Like Peptide-1 Receptor
0
Quinoxalines
0
Glucagon-Like Peptide 1
89750-14-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2502-2510Références
Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2607-2612
pubmed: 31405683
Diabetes. 2010 Dec;59(12):3099-107
pubmed: 20823098
Subcell Biochem. 2019;91:453-476
pubmed: 30888662
J Endocrinol. 2011 May;209(2):203-10
pubmed: 21372151
Front Endocrinol (Lausanne). 2019 Feb 26;10:75
pubmed: 30863364
Front Psychiatry. 2019 Jan 28;9:781
pubmed: 30745885
J Clin Invest. 2005 Dec;115(12):3318-25
pubmed: 16322775
Diabetologia. 2013 Sep;56(9):1878-83
pubmed: 23748861
PLoS One. 2014 Sep 02;9(9):e105683
pubmed: 25180755
J Endocrinol. 2018 Jan;236(1):R29-R42
pubmed: 28855317
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):937-42
pubmed: 17213325
Biochem Biophys Res Commun. 2012 Jan 6;417(1):558-63
pubmed: 22177947
J Biol Chem. 2008 Mar 28;283(13):8723-35
pubmed: 18216022
Acta Pharmacol Sin. 2012 Feb;33(2):148-54
pubmed: 22301855
JBMR Plus. 2019 Aug 23;3(10):e10209
pubmed: 31687645
Endocrinology. 2011 Jan;152(1):1-3
pubmed: 21183707
Sci Rep. 2016 Mar 22;6:23367
pubmed: 27000963
Regul Pept. 2010 Jan 8;159(1-3):61-6
pubmed: 19586609
Oncotarget. 2017 Dec 27;9(7):7372-7388
pubmed: 29484117
J Bone Miner Res. 2013 Jul;28(7):1641-52
pubmed: 23427056
Drug Discov Today. 2005 Mar 15;10(6):417-27
pubmed: 15808821
Life Sci. 2013 Mar 21;92(10):533-40
pubmed: 23357248
Ann Transl Med. 2019 Aug;7(16):369
pubmed: 31555683
Endocrine. 2015 Feb;48(1):107-15
pubmed: 25074632
PLoS One. 2014 Apr 02;9(4):e93746
pubmed: 24695667
PLoS One. 2016 Feb 10;11(2):e0148827
pubmed: 26863436
Biochem Biophys Res Commun. 2019 Aug 13;516(1):300-306
pubmed: 31256933
Pharmacol Rev. 2016 Oct;68(4):954-1013
pubmed: 27630114
Front Endocrinol (Lausanne). 2017 May 03;8:98
pubmed: 28515711
Int J Mol Sci. 2018 Aug 28;19(9):
pubmed: 30154383
BMC Musculoskelet Disord. 2019 Nov 13;20(1):532
pubmed: 31722698
Int J Neurosci. 2021 May 3;:1-38
pubmed: 33941038
Sci Rep. 2019 Sep 20;9(1):13651
pubmed: 31541189
J Bone Miner Metab. 2019 May;37(3):563-572
pubmed: 30238428
Endocrinology. 2011 Aug;152(8):3103-12
pubmed: 21693680
J Bone Miner Res. 1996 Mar;11(3):337-49
pubmed: 8852944
Arch Osteoporos. 2020 Feb 24;15(1):26
pubmed: 32095898
Exp Ther Med. 2018 Jun;15(6):5077-5083
pubmed: 29805533
DNA Cell Biol. 2018 Dec;37(12):1031-1043
pubmed: 30403540
Curr Diab Rep. 2016 Dec;16(12):120
pubmed: 27766579
PLoS One. 2015 Jul 15;10(7):e0132744
pubmed: 26177280
Physiol Behav. 2010 Feb 9;99(2):175-80
pubmed: 19555704
Eur J Pharmacol. 2010 Feb 25;628(1-3):268-73
pubmed: 19917278
ChemMedChem. 2018 Apr 6;13(7):662-671
pubmed: 29430842
Bone Res. 2018 Jun 14;6:19
pubmed: 29928541
J Bone Miner Metab. 2015 Nov;33(6):658-65
pubmed: 25300746